United States Beta Glucan and Fucoidan Market Insight
Published: 13 June 2026 | Report Format: Electronic (PDF)
The United States Beta Glucan and Fucoidan Market is projected to grow at a CAGR of 7.1%, driven by increasing consumer preference for immune health supplements, rising demand for natural bioactive ingredients, expanding nutraceutical applications, and growing scientific validation supporting their therapeutic benefits.
United States Beta Glucan and Fucoidan Market Forecasts to 2035
- The United States Beta Glucan and Fucoidan Market Size was Estimated at USD 0.58 Billion in 2025.
- The Market Size is Expected to Grow at a CAGR of around 7.1% from 2025 to 2035.
- The United States Beta Glucan and Fucoidan Market Size is Expected to Reach around USD 1.15 Billion by 2035.
Notable Insights in the United States Beta Glucan and Fucoidan Market
- Segmentation Based on Product Type, the Beta Glucan segment held a dominant position in the United States Beta Glucan and Fucoidan Market in 2025 with nearly 68.4% share, supported by extensive use in dietary supplements, immune health formulations, and functional nutrition products.
- Segmentation Based on Application, the Dietary Supplements segment accounted for approximately 54.9% share in 2025, driven by increasing preventive healthcare awareness, growing supplement consumption, and rising preference for naturally derived ingredients.
- The United States Beta Glucan and Fucoidan Market is led by Kerry Group plc, Gencor Pacific Group, and Marinova Pty Ltd, with combined revenues of approximately USD 10.87 billion in 2025, reflecting strong capabilities across nutraceutical ingredient innovation and commercialization.
- Growing consumer demand for clinically supported immune ingredients is accelerating market expansion, while Kerry Group reported USD 9.44 billion, Gencor Pacific generated approximately USD 0.98 billion, and Marinova recorded nearly USD 0.45 billion in revenues during 2025, strengthening competitive intensity and product development activities.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- Intelligent Market Research Based on AI for Semiconductors & Optoelectronics
Decisions Advisors offers intelligent market research which includes advanced analysis of infrared sensor technologies, optoelectronic semiconductors, AI-driven sensing solutions, and remote sensing. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in South Korea Remote Sensing Infrared Light Emitting Diode Market.
- Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the semiconductor value chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for semiconductor solutions in automotive electronics, industrial automation, health care monitoring, and smart surveillance applications in South Korea.
- Highly Competitive Environment Analysis
In-depth analysis of key infrared LED players, optoelectronic semiconductor innovations, AI-enabled sensing solutions, product launch activities, and collaborations is included in the report. The report also covers semiconductor regulations, technology research and development analysis, smart sensor infrastructure, and new opportunities available in the South Korea Remote Sensing Infrared Light Emitting Diode Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States beta glucan and fucoidan market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in the United States Beta Glucan and Fucoidan Market
- Kerry Group plc
- Gencor Pacific Group
- Marinova Pty Ltd
- Cargill, Incorporated
- Tate & Lyle PLC
- Kemin Industries
- Super Beta Glucan Inc.
- Biothera Pharmaceuticals, Inc.
- Ceapro Inc.
- Nutra Green Biotechnology Co., Ltd.
Recent Developments:
- In February 2025, Marinova Pty Ltd launched an expanded fucoidan ingredient portfolio targeting premium immune health and healthy aging supplement applications, supported by enhanced extraction and purification capabilities.
- In April 2025, Kerry Group plc collaborated with a leading United States nutraceutical manufacturer to develop next-generation immune health formulations incorporating proprietary beta glucan ingredients for preventive wellness applications.
Market Segmentation:
United States Beta Glucan and Fucoidan Market, By Product Type
- Beta Glucan
- Fucoidan
United States Beta Glucan and Fucoidan Market, By Source
- Yeast
- Mushrooms
- Cereals
- Brown Seaweed
- Others
United States Beta Glucan and Fucoidan Market, By Form
- Powder
- Capsules
- Liquid
- Tablets
- Others
United States Beta Glucan and Fucoidan Market, By Application
- Dietary Supplements
- Functional Foods & Beverages
- Pharmaceuticals
- Animal Nutrition
- Personal Care & Cosmetics
- United States Beta Glucan and Fucoidan Market, By Distribution Channel
- Direct Sales
- Specialty Stores
- Pharmacies & Drug Stores
- Online Retail
- Others
United States Beta Glucan and Fucoidan Market, By End User
- Adults
- Geriatric Population
- Sports Nutrition Consumers
- Healthcare Institutions
Expert Views:
The United States Beta Glucan and Fucoidan Market is anticipated to witness significant growth through 2035, supported by rising consumer focus on preventive healthcare, increasing acceptance of scientifically validated nutraceutical ingredients, and expanding applications in dietary supplements and functional nutrition. Strategic product launches and collaborations are expected to intensify competition and accelerate innovation across immune health and wellness segments.
Author: Govind and Krishna By Decisions Advisors and Consulting